Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 29 | 2018 | 772 | 5.830 |
Why?
|
Sexually Transmitted Diseases | 12 | 2014 | 91 | 2.190 |
Why?
|
Patient Acceptance of Health Care | 9 | 2017 | 238 | 1.850 |
Why?
|
South Africa | 17 | 2018 | 60 | 1.720 |
Why?
|
Rural Population | 10 | 2018 | 136 | 1.700 |
Why?
|
Reagent Kits, Diagnostic | 3 | 2016 | 39 | 1.530 |
Why?
|
Community Networks | 5 | 2017 | 29 | 1.220 |
Why?
|
Brazil | 19 | 2015 | 69 | 1.180 |
Why?
|
Self Care | 4 | 2016 | 164 | 1.170 |
Why?
|
Sexual Behavior | 8 | 2015 | 302 | 1.110 |
Why?
|
Sexual Partners | 7 | 2018 | 93 | 1.020 |
Why?
|
Social Stigma | 4 | 2017 | 52 | 0.990 |
Why?
|
Social Environment | 5 | 2013 | 188 | 0.970 |
Why?
|
Homosexuality, Male | 4 | 2016 | 298 | 0.960 |
Why?
|
AIDS Serodiagnosis | 4 | 2017 | 25 | 0.920 |
Why?
|
Health Services Accessibility | 3 | 2016 | 394 | 0.900 |
Why?
|
Sex Workers | 2 | 2013 | 9 | 0.880 |
Why?
|
Unsafe Sex | 4 | 2012 | 42 | 0.880 |
Why?
|
Condoms | 5 | 2015 | 36 | 0.870 |
Why?
|
Mass Screening | 4 | 2017 | 618 | 0.860 |
Why?
|
Health Promotion | 4 | 2017 | 160 | 0.800 |
Why?
|
Community Health Services | 3 | 2017 | 80 | 0.790 |
Why?
|
Program Evaluation | 2 | 2014 | 297 | 0.780 |
Why?
|
Sex Work | 5 | 2012 | 12 | 0.730 |
Why?
|
Interviews as Topic | 9 | 2017 | 319 | 0.720 |
Why?
|
Risk-Taking | 5 | 2018 | 148 | 0.680 |
Why?
|
Adolescent | 23 | 2018 | 8981 | 0.660 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2017 | 508 | 0.640 |
Why?
|
Counseling | 3 | 2017 | 145 | 0.600 |
Why?
|
Adult | 32 | 2018 | 25648 | 0.600 |
Why?
|
Young Adult | 20 | 2017 | 5976 | 0.580 |
Why?
|
Behavior Rating Scale | 1 | 2016 | 6 | 0.570 |
Why?
|
Male | 31 | 2018 | 40966 | 0.560 |
Why?
|
Community Participation | 1 | 2016 | 36 | 0.550 |
Why?
|
Anti-Retroviral Agents | 1 | 2016 | 30 | 0.550 |
Why?
|
Text Messaging | 1 | 2016 | 27 | 0.540 |
Why?
|
Continuity of Patient Care | 2 | 2017 | 169 | 0.530 |
Why?
|
Patient Dropouts | 1 | 2015 | 28 | 0.530 |
Why?
|
Clinical Protocols | 1 | 2016 | 156 | 0.530 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 64 | 0.520 |
Why?
|
Bisexuality | 1 | 2015 | 32 | 0.520 |
Why?
|
Humans | 48 | 2018 | 86644 | 0.500 |
Why?
|
Psychometrics | 1 | 2016 | 327 | 0.490 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 102 | 0.490 |
Why?
|
Transgender Persons | 1 | 2016 | 95 | 0.490 |
Why?
|
Preventive Health Services | 1 | 2014 | 37 | 0.480 |
Why?
|
Masculinity | 1 | 2013 | 10 | 0.480 |
Why?
|
Surveys and Questionnaires | 9 | 2017 | 2501 | 0.470 |
Why?
|
Domestic Violence | 1 | 2013 | 24 | 0.470 |
Why?
|
Social Participation | 1 | 2013 | 14 | 0.450 |
Why?
|
Health Personnel | 1 | 2015 | 202 | 0.440 |
Why?
|
Adolescent Health Services | 1 | 2012 | 11 | 0.430 |
Why?
|
San Francisco | 5 | 2016 | 21 | 0.420 |
Why?
|
Self-Examination | 2 | 2013 | 4 | 0.420 |
Why?
|
Socioeconomic Factors | 9 | 2016 | 567 | 0.420 |
Why?
|
Reproductive Health Services | 1 | 2012 | 20 | 0.420 |
Why?
|
Female | 29 | 2018 | 44533 | 0.420 |
Why?
|
Patient Compliance | 2 | 2017 | 227 | 0.400 |
Why?
|
Patient Preference | 1 | 2012 | 105 | 0.400 |
Why?
|
Attitude | 1 | 2012 | 127 | 0.390 |
Why?
|
Global Health | 2 | 2013 | 193 | 0.380 |
Why?
|
Models, Statistical | 2 | 2010 | 574 | 0.360 |
Why?
|
Probability | 1 | 2010 | 355 | 0.350 |
Why?
|
Papillomaviridae | 1 | 2010 | 153 | 0.340 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 394 | 0.340 |
Why?
|
Focus Groups | 3 | 2016 | 155 | 0.330 |
Why?
|
Motor Vehicles | 1 | 2007 | 18 | 0.310 |
Why?
|
Health Services Administration | 1 | 2007 | 2 | 0.310 |
Why?
|
Vaginal Smears | 1 | 2007 | 68 | 0.300 |
Why?
|
Travel | 1 | 2007 | 68 | 0.300 |
Why?
|
Occupational Diseases | 1 | 2007 | 55 | 0.300 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2010 | 275 | 0.290 |
Why?
|
Cross-Sectional Studies | 7 | 2017 | 1621 | 0.290 |
Why?
|
Health Services | 1 | 2007 | 55 | 0.290 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 239 | 0.290 |
Why?
|
International Cooperation | 1 | 2007 | 127 | 0.290 |
Why?
|
Middle Aged | 12 | 2017 | 25028 | 0.290 |
Why?
|
Qualitative Research | 3 | 2017 | 256 | 0.280 |
Why?
|
Pilot Projects | 4 | 2016 | 839 | 0.280 |
Why?
|
Residence Characteristics | 4 | 2015 | 197 | 0.240 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 220 | 0.230 |
Why?
|
Herpes Genitalis | 2 | 2015 | 41 | 0.230 |
Why?
|
Prejudice | 2 | 2016 | 49 | 0.210 |
Why?
|
Alcohol Drinking | 2 | 2015 | 267 | 0.210 |
Why?
|
Sex Factors | 2 | 2017 | 1054 | 0.210 |
Why?
|
Cluster Analysis | 2 | 2017 | 369 | 0.210 |
Why?
|
Pain | 1 | 2003 | 391 | 0.200 |
Why?
|
HIV-1 | 2 | 2014 | 163 | 0.190 |
Why?
|
Trichomonas vaginalis | 2 | 2013 | 2 | 0.190 |
Why?
|
Risk Factors | 7 | 2016 | 5417 | 0.190 |
Why?
|
Leiomyoma | 1 | 2003 | 191 | 0.180 |
Why?
|
Uterine Neoplasms | 1 | 2003 | 227 | 0.180 |
Why?
|
Perception | 2 | 2017 | 168 | 0.180 |
Why?
|
Early Diagnosis | 2 | 2017 | 131 | 0.170 |
Why?
|
Poverty | 2 | 2012 | 173 | 0.160 |
Why?
|
Intimate Partner Violence | 1 | 2018 | 20 | 0.160 |
Why?
|
Prevalence | 5 | 2018 | 1239 | 0.160 |
Why?
|
Herpesvirus 2, Human | 2 | 2015 | 45 | 0.150 |
Why?
|
Rural Health | 1 | 2017 | 20 | 0.150 |
Why?
|
Feasibility Studies | 2 | 2016 | 751 | 0.150 |
Why?
|
HIV Seroprevalence | 1 | 2016 | 9 | 0.150 |
Why?
|
Alcoholism | 1 | 2018 | 172 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 66 | 0.140 |
Why?
|
Public Facilities | 1 | 2016 | 1 | 0.140 |
Why?
|
Polymerase Chain Reaction | 2 | 2009 | 927 | 0.140 |
Why?
|
Attitude to Health | 1 | 2017 | 220 | 0.140 |
Why?
|
Poverty Areas | 2 | 2014 | 37 | 0.140 |
Why?
|
Medication Adherence | 1 | 2017 | 129 | 0.130 |
Why?
|
Social Control, Informal | 1 | 2015 | 5 | 0.130 |
Why?
|
Social Support | 2 | 2015 | 193 | 0.130 |
Why?
|
Sample Size | 1 | 2016 | 130 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 153 | 0.130 |
Why?
|
South America | 1 | 2015 | 29 | 0.130 |
Why?
|
Alcoholic Beverages | 1 | 2015 | 13 | 0.130 |
Why?
|
Life Change Events | 1 | 2015 | 48 | 0.130 |
Why?
|
Laboratory Proficiency Testing | 1 | 2014 | 5 | 0.130 |
Why?
|
Social Perception | 1 | 2016 | 95 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2018 | 313 | 0.130 |
Why?
|
Program Development | 1 | 2015 | 124 | 0.130 |
Why?
|
Shame | 1 | 2014 | 4 | 0.130 |
Why?
|
Blood | 1 | 2014 | 69 | 0.130 |
Why?
|
North America | 1 | 2015 | 180 | 0.130 |
Why?
|
Veterans | 1 | 2015 | 72 | 0.130 |
Why?
|
Urban Population | 2 | 2014 | 213 | 0.120 |
Why?
|
Data Collection | 1 | 2016 | 372 | 0.120 |
Why?
|
Viral Load | 1 | 2014 | 148 | 0.120 |
Why?
|
Health Surveys | 3 | 2014 | 239 | 0.120 |
Why?
|
Military Personnel | 1 | 2015 | 85 | 0.120 |
Why?
|
Regression Analysis | 3 | 2010 | 596 | 0.120 |
Why?
|
Heterosexuality | 1 | 2013 | 17 | 0.120 |
Why?
|
Social Marginalization | 1 | 2013 | 2 | 0.120 |
Why?
|
Gonorrhea | 2 | 2010 | 18 | 0.110 |
Why?
|
Chlamydia Infections | 2 | 2010 | 25 | 0.110 |
Why?
|
Trichomonas Vaginitis | 1 | 2013 | 1 | 0.110 |
Why?
|
Parasitology | 1 | 2013 | 2 | 0.110 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2013 | 78 | 0.110 |
Why?
|
Health Education | 1 | 2013 | 101 | 0.110 |
Why?
|
Men's Health | 1 | 2012 | 6 | 0.110 |
Why?
|
Self Efficacy | 1 | 2012 | 53 | 0.110 |
Why?
|
Crime Victims | 1 | 2012 | 34 | 0.110 |
Why?
|
Confidentiality | 1 | 2012 | 78 | 0.100 |
Why?
|
Safe Sex | 1 | 2012 | 23 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 141 | 0.100 |
Why?
|
Reproducibility of Results | 2 | 2016 | 2705 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2015 | 1019 | 0.100 |
Why?
|
Hepatitis B | 1 | 2011 | 74 | 0.100 |
Why?
|
Delivery of Health Care | 1 | 2016 | 426 | 0.100 |
Why?
|
Logistic Models | 5 | 2014 | 1186 | 0.090 |
Why?
|
Violence | 1 | 2012 | 143 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2011 | 293 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2014 | 999 | 0.090 |
Why?
|
Social Identification | 1 | 2010 | 24 | 0.090 |
Why?
|
Cervix Uteri | 1 | 2010 | 65 | 0.090 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 636 | 0.090 |
Why?
|
Self Disclosure | 1 | 2008 | 31 | 0.080 |
Why?
|
Stereotyping | 1 | 2008 | 13 | 0.080 |
Why?
|
Computers | 1 | 2008 | 112 | 0.080 |
Why?
|
Computing Methodologies | 1 | 2008 | 9 | 0.080 |
Why?
|
Health Status | 1 | 2010 | 360 | 0.080 |
Why?
|
Permissiveness | 1 | 2007 | 1 | 0.080 |
Why?
|
Truth Disclosure | 1 | 2008 | 87 | 0.080 |
Why?
|
DNA, Protozoan | 1 | 2007 | 16 | 0.080 |
Why?
|
Chlamydia trachomatis | 1 | 2007 | 14 | 0.080 |
Why?
|
Neisseria gonorrhoeae | 1 | 2007 | 16 | 0.080 |
Why?
|
Italy | 2 | 2003 | 106 | 0.070 |
Why?
|
Gender Identity | 2 | 2018 | 52 | 0.070 |
Why?
|
DNA, Bacterial | 1 | 2007 | 236 | 0.070 |
Why?
|
Cohort Studies | 1 | 2013 | 2767 | 0.070 |
Why?
|
Odds Ratio | 1 | 2007 | 678 | 0.070 |
Why?
|
Commerce | 2 | 2015 | 29 | 0.070 |
Why?
|
Pain, Intractable | 1 | 2003 | 11 | 0.060 |
Why?
|
Premenopause | 1 | 2003 | 54 | 0.060 |
Why?
|
Dyspareunia | 1 | 2003 | 19 | 0.060 |
Why?
|
Prospective Studies | 1 | 2012 | 4214 | 0.060 |
Why?
|
Postmenopause | 1 | 2003 | 98 | 0.060 |
Why?
|
Dysmenorrhea | 1 | 2003 | 49 | 0.060 |
Why?
|
Polychlorinated Dibenzodioxins | 1 | 2002 | 3 | 0.060 |
Why?
|
Menstrual Cycle | 1 | 2002 | 55 | 0.050 |
Why?
|
Environmental Pollutants | 1 | 2002 | 51 | 0.050 |
Why?
|
Contact Tracing | 2 | 2014 | 29 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2002 | 296 | 0.050 |
Why?
|
Baths | 1 | 2016 | 8 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 12 | 0.040 |
Why?
|
Iraq War, 2003-2011 | 1 | 2015 | 3 | 0.030 |
Why?
|
Afghan Campaign 2001- | 1 | 2015 | 4 | 0.030 |
Why?
|
Peru | 1 | 2015 | 24 | 0.030 |
Why?
|
California | 1 | 2015 | 138 | 0.030 |
Why?
|
RNA, Viral | 1 | 2014 | 327 | 0.030 |
Why?
|
Social Conditions | 1 | 2012 | 8 | 0.030 |
Why?
|
Multilevel Analysis | 1 | 2012 | 21 | 0.030 |
Why?
|
New York City | 1 | 2012 | 59 | 0.030 |
Why?
|
Social Values | 1 | 2012 | 44 | 0.030 |
Why?
|
Propensity Score | 1 | 2012 | 136 | 0.030 |
Why?
|
Research Design | 1 | 2015 | 594 | 0.030 |
Why?
|
Seroepidemiologic Studies | 1 | 2011 | 55 | 0.030 |
Why?
|
Hepatitis B virus | 1 | 2011 | 43 | 0.030 |
Why?
|
Syphilis | 1 | 2011 | 27 | 0.020 |
Why?
|
Population | 1 | 2010 | 35 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 59 | 0.020 |
Why?
|
Social Desirability | 1 | 2010 | 12 | 0.020 |
Why?
|
Social Change | 1 | 2010 | 7 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 251 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2011 | 456 | 0.020 |
Why?
|
Linear Models | 1 | 2010 | 421 | 0.020 |
Why?
|
Transportation | 1 | 2008 | 18 | 0.020 |
Why?
|
Trichomonas Infections | 1 | 2008 | 1 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 2008 | 48 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 1991 | 0.020 |
Why?
|
Bias | 1 | 2008 | 127 | 0.020 |
Why?
|
Social Isolation | 1 | 2008 | 67 | 0.020 |
Why?
|
Primary Health Care | 1 | 2011 | 339 | 0.020 |
Why?
|
Animals | 1 | 2007 | 26582 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 157 | 0.020 |
Why?
|
Chemical Industry | 1 | 2002 | 1 | 0.010 |
Why?
|
Explosions | 1 | 2002 | 6 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 7993 | 0.010 |
Why?
|
Biomarkers | 1 | 2008 | 1718 | 0.010 |
Why?
|
Aged | 1 | 2012 | 18415 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2002 | 3640 | 0.010 |
Why?
|